Test identifies patients who benefit from targeted cancer drugs

[heblaj01]

The research study published at ASCO 2006 is too fresh to allow confirmation of results by other investigators.
The last link below is a comment on the subject in a message board.

http://www.european-hospital.com/en/issues/articleview.php?id=239
Test identifies patients who benefit from targeted cancer drugs (16 july 2006)

http://www.weisenthal.org/asco_06_eg...weisenthal.htm
Gefitinib-induced cell death in short term fresh tumor cultures predicts for long term patient survival in previously-treated non-small cell lung cancer (ASCO june 2006)

http://www.cancercompass.com/message-board/message/all,5580,0.htm
Message Board Discussions
Targeted, Angiogenesis Assay Development (6 june 2006)